Top Banner
1 GUIDE FOR AUTHORS (Revised May 2015) Contents (click on a topic) Manuscript Types Articles Perspectives Reviews Letters Application Notes Editorials Additions and Corrections Retractions QSAR/QPSR Submissions Preparation of Manuscript Submission of Manuscript Revision of Manuscript Publication of Manuscript The Journal of Chemical Information and Modeling invites new and original contributions with the understanding that if accepted, they will not be published elsewhere. Papers reporting new methodology and/or important applications in the fields of chemical informatics or molecular modeling are appropriate for submission to this Journal. Specific topics include the representation and computer-based searching of chemical databases, molecular modeling, computer-aided molecular design of new materials, catalysts, or ligands, development of new computational methods or efficient algorithms for chemical software, and biopharmaceutical chemistry including analyses of biological activity and other issues related to drug discovery.
11

Binding Activity Prediction of Cyclin-Dependent Inhibitors

May 01, 2023

Download

Documents

Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Binding Activity Prediction of Cyclin-Dependent Inhibitors

1

GUIDE FOR AUTHORS

(Revised May 2015)

Contents (click on a topic)

Manuscript Types – Articles – Perspectives – Reviews – Letters – Application Notes – Editorials – Additions and Corrections – Retractions – QSAR/QPSR Submissions

Preparation of Manuscript

Submission of Manuscript

Revision of Manuscript

Publication of Manuscript

The Journal of Chemical Information and Modeling invites new and original contributions

with the understanding that if accepted, they will not be published elsewhere. Papers

reporting new methodology and/or important applications in the fields of chemical

informatics or molecular modeling are appropriate for submission to this Journal. Specific

topics include the representation and computer-based searching of chemical databases,

molecular modeling, computer-aided molecular design of new materials, catalysts, or

ligands, development of new computational methods or efficient algorithms for chemical

software, and biopharmaceutical chemistry including analyses of biological activity and

other issues related to drug discovery.

Page 2: Binding Activity Prediction of Cyclin-Dependent Inhibitors

2

Manuscript Types

Articles. Full-length research manuscripts, consistent with the objectives of the Journal of

Chemical Information and Modeling, are the principal focus of the Journal. Authors must follow

the instructions for preparation and submission given below.

Perspectives. Perspectives are interpretive accounts on subjects of current interest to the JCIM

community. This series is intended to be a forum for experts to present their perspectives on

emerging or active areas of research.

Reviews. Reviews are topical, brief (~8–10 printed pages), and of general interest to the JCIM

community. These papers critically evaluate existing work and make the material more easily

comprehendible to those not expert in the subject matter. Manuscripts must be ~5000 words and

should contain ≤100 references. The use of graphics to illustrate key concepts (3–5 display

items) is strongly encouraged. A submission should include ~8–10 keywords extracted from the

text as well as a graphical Table of Contents entry consisting of a colorful figure that represents

the topic of the paper. Authors are encouraged to send a pre-submission inquiry to the editorial

team for approval prior to submitting a review to the journal. The pre-submission inquiry should

contain a brief summary of the proposed review and its significance to the field. For pre-

submission inquiries, please email the journal at mailto:[email protected].

Letters. Letters are intended for rapid publication of preliminary reports on important findings of

novel and timely significance. The major concepts of the paper should not have been published

previously. Manuscripts are limited to four journal pages (16 double-spaced manuscript pages

including all materials). The abstract is limited to 75 words and should briefly state the purpose

of the research, principal results, and major conclusions. Supporting Information can be provided

detailing procedures or providing supplementary data.

Application Notes. Application notes are informative peer-reviewed reports on novel software

packages, databases, and web servers. Submissions should be no longer than 6 pages (approx.

5000 words) and contain at least one figure. The name of the application being described should

be clearly stated in the manuscript title. The scientific, technical, or other usability advancements

of the software should be clearly described. As far as possible, the software packages and web

servers should be operating system agnostic (Windows, Linux, and OSX). All submitted

manuscripts will be reviewed by an editor prior to being sent out for peer-review. The software

should be generally available for evaluation or purchase at the time of publication for academic

and commercial use. The software must be made available for testing by reviewers to address

specific data or claims in the manuscript, upon request by reviewers, while preserving reviewer

anonymity. Articles viewed to be unsuitable for the journal or inconsistent with the above

guidelines will be returned after editorial review.

Editorials. Readers are encouraged to provide scholarly comment on papers appearing in the

Journal. Both comments and responses are termed “Editorials”. Comments must raise scientific

or technical questions about an article; correspondence that is mainly opinion will not be

accepted. Correspondence should be submitted within six months of the date of publication of

the original article. The author(s) of the original article will be allowed to respond. Contributions

may be edited for length and clarity. Correspondence is peer-reviewed at the option of the Editor.

Page 3: Binding Activity Prediction of Cyclin-Dependent Inhibitors

3

Additions and Corrections. Additions and Corrections may be used to address important issues

or correct errors and omissions of consequence that arise after publication of an article.

Additions and Corrections may be requested by the author(s) or initiated by the Editor after

discussions with the corresponding author. Readers who detect errors of consequence in the work

of others should contact the corresponding author of that work. All Additions and Corrections

are subject to approval by the Editor, and minor corrections and additions will not be published.

Additions and Corrections from authors should be submitted via the ACS Paragon Plus

environment by the corresponding author for publication in the “Addition/Correction” section of

the Journal. The corresponding author should obtain approval from all of the article coauthors

prior to submitting an Addition and Correction or provide evidence that such approval has been

solicited. The Addition and Correction should include the original article title and author list,

citation including DOI, and details of the correction. For proper formatting, see examples in a

current issue of the Journal.

Retractions. Articles may be retracted for scientific or ethical reasons. Articles that contain

seriously flawed or erroneous data such that their findings and conclusions cannot be relied upon

may be retracted in order to correct the scientific record. Retractions may be requested by the

article author(s) or by the Journal Editor(s) but are ultimately published at the discretion of the

Editor. When an article is retracted, a notice of Retraction will be published containing

information about the original article title, author list, and the reason for the Retraction.

Retracted articles will be accompanied by the related Retraction notice and will be marked as

“Retracted”. The originally published article will remain on the web except in extraordinary

circumstances (e.g., where deemed legally necessary or if the availability of the published

content poses public health risks). The American Chemical Society follows guidance from the

Committee on Publication Ethics (COPE) when considering retractions; for more information,

see http://publicationethics.org/.

QSAR/QSPR Submissions. An editorial was published on guidelines for QSAR/QSPR papers:

J. Chem. Inf. Model. 2006, 46, 937. Submissions in this area need to follow the guidelines.

Compound Characterization. If the submission contains reports of new experimental data, the

same guidelines as required by the Journal of Medicinal Chemistry must be followed.

Supporting evidence must be provided for identification of the chemical structure and purity of

any compound that is reported to be active in an assay. This normally requires inclusion of NMR

spectra, molecular weight verification by high-resolution mass spectrometry, and HPLC data

verifying purity at the 95% or greater level.

Manuscripts must be submitted electronically via the secure Web site at

http://pubs.acs.org/page/4authors/submission/index.html. Guidelines for this method are

provided here. If substantially the same manuscript has been previously submitted to this Journal

or to another ACS journal, the author should include copies of the reviews with the submission

and explain any revisions in the cover letter. The Editor may accept the manuscript on the basis

of those reviews and author remarks or may seek additional reviews.

For further inquiries contact the Editor-in-Chief, Prof. Kenneth M. Merz, Jr., Department of

Chemistry, Michigan State University, 578 S. Shaw Lane, East Lansing, MI 48824-1322. Phone:

517-355-9715. Fax: 517-353-7248. E-mail: [email protected].

Page 4: Binding Activity Prediction of Cyclin-Dependent Inhibitors

4

Preparation of Manuscript

Preparation. The manuscript should be prepared, preferably with a word-processing package,

using all the guidelines described above. The title, abstract, text, and references should be

prepared as described above. Detailed instructions for submitting via the Web, including

templates and directions for preparing and including graphics, are available at

http://pubs.acs.org/page/4authors/submission/index.html. A separate file containing a cover letter

must also be prepared.

A guide to the proper format for manuscripts is provided on the Journal’s Web page, on

http://pubs.acs.org. Another valuable resource is The ACS Style Guide, 3rd ed. (2006) available

from Oxford University Press, Order Department, 201 Evans Rd, Cary, NC 27513. This book

deals with all questions relating to manuscript style and provides the standard list of

abbreviations for ACS Journals.

Preparing and Submitting Manuscripts Using TeX/LaTeX. Authors who submit manuscripts composed in TeX/LaTeX should submit a PDF file of the manuscript along with the native TeX/LaTeX manuscript package as a ZIP Archive. Use of the freely available achemso style package to help prepare your submission is strongly encouraged. The achemso package provides the official macros (achemso.cls) and BibTeX styles (achemso.bst and biochem.bst) for submission to ACS journals. The package and instructions are available from CTAN, the Comprehensive TeX Archive Network. For complete information on submitting TeX/LaTeX files, see Preparing and Submitting Manuscripts Using TeX/LaTeX.

Title. The title of the paper should be brief—preferably 12 words or fewer. Readers rarely read

and absorb longer titles, so it should be concise. An abstract of 3–4 sentences is required, and as

with the title, it should be concise, touching on just the major points about which the author

wants to alert the reader.

Text. A list of currently acceptable software packages can be found at

http://pubs.acs.org/page/4authors/submission/index.html. Manuscripts may also be written in

LaTeX. The instructions can be found at

http://pubs.acs.org/page/4authors/submission/index.html.

The article should conform to the usual ACS format, which is described at http://pubs.acs.org.

The final version should be prepared in a single word-processor file, with all graphics included.

The word-processor file should be saved in a document format (.wpd or .doc) not in the .txt or

ASCII formats, which do not support enhancements such as subscripts. Text should be single-

column, fully justified. If a non-Western version of a word-processing software is used, the file

should be saved in rich-text format (RTF). Each file should be checked with an up-to-date virus

detection program. The presence of a virus may delay publication.

The fonts “Times” and “Symbol” produce the best results. Other fonts, particularly those that do

not come bundled with the system software, may not translate properly. All special characters

(e.g., Greek characters, math symbols, etc.) must be present in the body of the text as characters

and not as graphic representations.

Page 5: Binding Activity Prediction of Cyclin-Dependent Inhibitors

5

Graphics. To facilitate the publication process, please submit manuscript graphics using the

following guidelines:

1. The preferred submission procedure is to embed graphic files in a Word document. It

may help to print the manuscript on a laser printer to ensure all artwork is clear and

legible.

2. Additional acceptable file formats are: TIFF, PDF, EPS (vector artwork) or CDX

(ChemDraw file). If submitting individual graphic files in addition to them being

embedded in a Word document, ensure the files are named based on graphic function (i.e.

Scheme 1, Figure 2, Chart 3), not the scientific name. Labeling of all figure parts should

be present and the parts should be assembled into a single graphic.

EPS files: Ensure that all fonts are converted to outlines or embedded in the

graphic file. The document settings should be in RGB mode. NOTE: While

EPS files are accepted, the vector-based graphics will be rasterized for

production. Please see below for TIFF file production resolutions.

3. TIFF files (either embedded in a Word doc or submitted as individual files) should have

the following resolution requirements:

- Black & White line art: 1200 dpi

- Grayscale art (a monochromatic image containing shades of gray): 600 dpi

- Color art (RGB color mode): 300 dpi

The RGB and resolution requirements are essential for producing high-quality

graphics within the published manuscript. Graphics submitted in CMYK or at

lower resolutions may be used, however, the colors may not be consistent and

graphics of poor quality may not be able to be improved.

Most graphic programs provide an option for changing the resolution when

you are saving the image. Best practice is to save the graphic file at the final

resolution and size using the program used to create the graphic.

4. Graphics should be sized at the final production size when possible. Single column

graphics are preferred and can be sized up to 240 points wide (3.33 in.). Double column

graphics must be sized between 300 and 504 points (4.167 in. and 7 in.). All graphics

have a maximum depth of 660 points (9.167 in.) including the caption (please allow 12

pts for each line of caption text).

Consistently sizing letters and labels in graphics throughout your manuscript

will help ensure consistent graphic presentation for publication.

Page 6: Binding Activity Prediction of Cyclin-Dependent Inhibitors

6

5. A graphic must be submitted for use as in the Table of Contents and Abstract (for each

Article, Perspective, Letter, or Application Note). This graphic should give the reader a

quick visual representation of the essence of the paper without providing specific details.

The best images for these uses are simple, relatively free of text and technical characters,

and make use of color for visual impact. The TOC graphic should be in the form of a

structure, graph, drawing, or reaction scheme. Tables or spectra are not acceptable. The

author should submit a graphic in the actual size to be used for the TOC that will fit in an

area 1.375 in. high and 3.5 in. wide (3.6 cm × 8.9 cm). Larger images will be reduced to

fit within those dimensions. Type size of labels, formulas, or numbers within the graphic

must be legible. The page should be labeled “for Table of Contents use only” and contain

the title and authors of the paper. This item should be appended as the last page of the

manuscript.

6. For more information, please visit

http://pubs.acs.org/page/4authors/submission/index.html.

Color graphics should only be submitted if essential for clarity of communication. Color

reproduction will be provided at no cost to the author. Hard copy reprints of articles containing

color graphics however will be subject to a surcharge of $1 per reprint, in addition to the normal

reprint charges.

Chemical Structures. Structures should be produced with the use of a drawing program such as

ChemDraw. Structure drawing preferences (preset in the ACS Stylesheet in ChemDraw) are as

follows:

(1) As drawing settings select:

chain angle 120º

bond spacing 18% of width

fixed length 14.4 pt (0.508 cm, 0.2 in.)

bold width 2.0 pt (0.071 cm, 0.0278 in.)

line width 0.6 pt (0.021 cm, 0.0084 in.)

margin width 1.6 pt (0.056 cm, 0.0222 in.)

hash spacing 2.5 pt (0.088 cm, 0.0347 in.)

(2) As text settings select:

font Arial/Helvetica

size 10 pt

(3) Under the preferences choose:

units points

tolerances 5 pixels

(4) Under page setup choose:

Paper US Letter

Scale 100%

Other drawing packages should be modified as much as possible so that the parameters reflect

the above guidelines.

Page 7: Binding Activity Prediction of Cyclin-Dependent Inhibitors

7

Nomenclature. It is the responsibility of the authors to provide correct nomenclature.

Nomenclature should conform with current American usage. Insofar as possible, authors should

use systematic names, either Chemical Abstracts Service or IUPAC, in the Experimental Section.

Chemical Abstracts (CA) nomenclature rules are described in Appendix IV of the Chemical

Abstracts Index Guide. For CA nomenclature advice, authors should consult the Manager of

Nomenclature Services, Chemical Abstracts Service, P.O. Box 3012, Columbus, OH 43210-

0012. A name generation service is available for a fee through CAS Client Services, 2540

Olentangy River Road, P.O. Box 3343, Columbus, OH 43210-0334; telephone (614) 447-3870;

fax (614) 447-3747; or e-mail [email protected]. It is also acceptable to use semisynthetic or

generic names for certain specialized classes of compounds. In such a case, the name should

conform to the generally accepted nomenclature conventions for the compound class. Chemical

names for drugs are preferred. If these are not practical, generic names, or names approved by

the U.S. Adopted Names Council (USAN), or those approved by the World Health Organization

(WHO) may be used. Registered trademark names or code numbers for drugs can be included in

parentheses after a descriptive term in the title and should be used only once in the text;

subsequently, their chemical names or compound numbers should be used. In certain cases,

compounds that are widely employed as research tools and recognized primarily by code

numbers may be designated by their code numbers. If a generic name is employed, its chemical

name or structural formula should be given at the point of first citation.

References. References in the text should be identified with superscript numbers (e.g.,

Sustmann8 has shown...). In the HTML version of the Journal, each reference has a “CAS” tag

that can be used by readers to retrieve the corresponding CAS abstract, and for this to be

successful, accuracy in the reference is critical. References must contain the title and the starting

and ending pages of the paper cited, thus

(8) Sustmann, R.; Sicking, W.; Huisgen, R. A Computational Study of the Cycloaddition

of Thiobenzophenone S-Methylide to Thiobenzophenone. J. Am. Chem. Soc. 2003, 125,

14425–14434.

References to books should cite the author(s), title, publisher, publication date, and page(s). In

referring to a book written by various contributors, the author(s) should be cited first, as in

(8) Weinstein, S.; Henderson, R. B. In Heterocyclic Compounds; Elderfield, R. C., Ed.;

Wiley: New York, 1950; Vol. 1, Chapter 1, pp 60–65.

For work published online (ASAP) and work submitted for publication (e.g., submitted; in

press), the DOI should be furnished in addition to the standard bibliographic information.

Authors are given instruction for citing work by DOI in an e-mail communication when

manuscript proofs are made available. A DOI is assigned to each manuscript and should be in the

form http://dx.doi.org/10.1021/om000000a. DOI is an accepted form of citation before and after

the article appears in an issue.

Supporting Information. Authors are encouraged to use Supporting Information (SI) in cases

where manuscripts contain extensive tables of data or source codes that are of interest to

particular readers. The pages of SI should be numbered sequentially, should be labeled as SI, and

should be readily legible. The production staff will not alter the appearance or content of the

Supporting Information. A paragraph that briefly describes the Supporting Information,

providing only the information necessary to access the data, should be included.

Page 8: Binding Activity Prediction of Cyclin-Dependent Inhibitors

8

For Supporting Information included with the manuscript, files must be identified as publish or

review only. SI should not be included in the manuscript file but should be contained in its own

separate file. Supporting Information must be submitted at the same time as the manuscript and

uploaded separately to the ACS Paragon Plus Environment. A list of acceptable file types is

available on the Web. All Supporting Information files of the same type should be prepared as a

single file (rather than submitting a series of files containing individual images or structures). For

example, all Supporting Information available as PDF files should be contained in one PDF file.

Do not upload figures and tables that are to be published in the article into the

Supporting Information file.

Journal Publishing Agreement. A properly completed and signed Journal Publishing

Agreement must be submitted for each manuscript. ACS Paragon Plus provides an electronic

version of the Agreement that will be available on the My Authoring Activity tab of the

Corresponding Author's Home page once the manuscript has been assigned to an Editor. A PDF

version of the Agreement is also available, but Authors are strongly encouraged to use the

electronic Journal Publishing Agreement. If the PDF version is used, all pages of the signed

PDF Agreement must be submitted. If the Corresponding Author cannot or should not

complete either the electronic or PDF version for any reason, another Author should complete

and sign the PDF version of the form. Forms and complete instructions are available at

http://pubs.acs.org/page/copyright/journals/index.html.

Conflict of Interest Statement. A statement describing any financial conflicts of interest or lack

thereof is published with each manuscript. During the submission process, the corresponding

author must provide this statement on behalf of all authors of the manuscript. The statement

should describe all potential sources of bias, including affiliations, funding sources, and financial

or management relationships, that may constitute conflicts of interest (please see the ACS Ethical

Guidelines). The statement will be published in the final article. If no conflict of interest is

declared, the following statement will be published in the article: “The authors declare no

competing financial interest.”

Funding Sources. When submitting a manuscript to the Journal via ACS Paragon Plus, the submitting author is asked to identify the funding sources for the work presented in the manuscript. Identifying funding sources is optional during submission of an original manuscript. Funding source information is required when a revised manuscript is submitted.

Professional Ethics. In publishing only original research, ACS is committed to deterring

plagiarism, including self-plagiarism. ACS Publications uses CrossCheck's iThenticate software

to screen submitted manuscripts for similarity to published material. Note that your manuscript

may be screened during the submission process. Further information about plagiarism can be

found in Part B of the Ethical Guidelines to Publication of Chemical Research.

Author List. During manuscript submission, the submitting author must provide contact

information (full name, email address, institutional affiliation and mailing address) for all of the

co-authors. Because all of the author names are automatically imported into the electronic

Journal Publishing Agreement, the names must be entered into ACS Paragon Plus in the same

sequence as they appear on the first page of the manuscript. (Note that co-authors are not

Page 9: Binding Activity Prediction of Cyclin-Dependent Inhibitors

9

required to register in ACS Paragon Plus.) The author who submits the manuscript for

publication accepts the responsibility of notifying all co-authors that the manuscript is being

submitted. Deletion of an author after the manuscript has been submitted requires a confirming

letter to the Editor-in-Chief from the author whose name is being deleted. For more information

on ethical responsibilities of authors, see the Ethical Guidelines to Publication of Chemical

Research.

Patent Activities and Intellectual Property Issues. Authors are responsible for ensuring that all

patent activities and intellectual property issues are satisfactorily resolved prior to first

publication (Just Accepted, ASAP, or in issue). Acceptance and publication will not be delayed

for pending or unresolved issues of this nature.

Assistance with English Language Editing. Authors may want to have their manuscripts edited

professionally before submission to improve clarity. The ACS ChemWorx English Editing

Service can assist you in improving and polishing the language in your manuscript. You can

learn more about the services offered, at http://es.acschemworx.acs.org.

Submission of Manuscript

Cover Letter. A cover letter must accompany every manuscript. The cover letter is a word-

processor or PDF file that is uploaded at the same time as the manuscript file. The cover letter

should include (1) the corresponding author’s name, postal and e-mail addresses, and telephone

and fax numbers; (2) the title of the manuscript and a brief paragraph pointing out the

significance of the reported work; (3) indication of whether the manuscript is being submitted as

an Article, Perspective, etc.; and (4) the names, institutional affiliations, and postal and e-mail

addresses of three scientists qualified to act as reviewers. The Editors will also use reviewers of

their own choice.

Submission. Manuscripts must be submitted via the ACS Paragon Plus Environment

(http://paragonplus.acs.org/login). Complete instructions and an overview of the electronic

online (Web) submission process are available through the secure ACS Paragon Plus Web site.

Authors must also submit all revisions of manuscripts via the ACS Paragon Plus Environment.

The Web submission site employs state-of-the-art security mechanisms to ensure that all

electronically submitted papers are secure. These same security mechanisms are also utilized

throughout the peer-review process, permitting access only to editors and reviewers who are

assigned to a particular paper.

ORCID. All authors are encouraged to register for an ORCID iD, a unique researcher identifier. With this standard identifier, you can create a profile of your research activities to distinguish yourself from other researchers with similar names and make it easier for your colleagues to find your publications. Learn more at http://www.orcid.org.

Authors and reviewers can add their ORCID iD to, or register for an ORCID iD from, their account in ACS Paragon Plus. Submitting authors have the option to provide existing ORCID iDs for coauthors during submission, but they cannot create new ORCID iDs for coauthors.

Page 10: Binding Activity Prediction of Cyclin-Dependent Inhibitors

10

Revision of Manuscript

When reviews of the paper have been completed, they will be sent to the author electronically by

e-mail. The manuscript should be revised so as to address each one of the comments made by the

reviewers. Then the manuscript should be resubmitted through the Web site following the steps

for submitting a revised manuscript. A letter describing the responses made by the author to each

of the comments from the reviewers should also be sent. This letter is required and can be

submitted over the Web along with the revised manuscript. A Journal Publishing Agreement is

also required; the paper will not be processed further until both these documents are

received. Authors are strongly encouraged to use the electronic Journal Publishing Agreement in

Paragon Plus. Forms and complete instructions are available at

http://pubs.acs.org/page/copyright/journals/index.html.

Publication of Manuscript

When the paper is either rejected or accepted, the corresponding author will be notified

electronically of the decision.

Just Accepted Manuscripts. Just Accepted manuscripts are peer-reviewed, accepted manuscripts

that are published on the ACS Publications Web site prior to technical editing, formatting for

publication, and author proofing—usually within 30 minutes to 24 hours of acceptance by the

editorial office. During the manuscript submission process, Authors can choose to have their

manuscript posted online as a Just Accepted manuscript. To ensure rapid delivery of the accepted

manuscript to the Web, Authors must adhere carefully to all requirements in the journal’s Guide for

Authors. For further information, please refer to the Just Accepted FAQ, accessible from

http://help.acs.org. Note that publishing a manuscript as Just Accepted is not a means by which

to comply with the NIH Public Access Mandate.

Proofs. The corresponding author of an accepted manuscript will receive e-mail notification and

complete instructions when page proofs are available for review via a secure Web site. Authors

will access the secure site through ACS ChemWorx and will need an ACS ID. To obtain an ACS

ID or to reset your password, go to www.acschemworx.org. Proofs should be verified against the

final manuscript and corrected, as necessary. Please contact the ACS Journals Help Desk with

any questions about proof corrections. Once the galley corrections have been returned, the

author’s work is complete.

Routine rephrasing of sentences or additions are not permitted at the page proof stage.

Alterations should be restricted to serious changes in interpretation or corrections of data.

Extensive or important changes on page proofs, including changes to the title or list of authors,

are subject to Editorial review.

It is the responsibility of the corresponding author to ensure that all authors listed on the

manuscript agree with the changes made on the proofs. Galley proofs should be returned within

48 h of receipt in order to ensure timely publication of the manuscript.

Articles ASAP. Papers accepted for publication in the Journal will be published on the “Articles

ASAP” page on the Journal Web site as soon as page proofs are corrected and all author

concerns are resolved (may be within 48 h). Publication on the Web site usually occurs within 1–

Page 11: Binding Activity Prediction of Cyclin-Dependent Inhibitors

11

4 working days of receipt of page proof corrections, and this can be as much as 11 weeks prior to

appearance of the printed version. Manuscripts assigned to a special issue often remain published

ASAP for several months. Once a manuscript appears on the Web site, it is published. Any

change after that point must be considered additions or corrections. The actual date on which an

accepted paper is published on the Web site is recorded on the Web version of the manuscript

and on the first page of the PDF version.

There is no page charge associated with publication of papers in the Journal, and there is no

charge for publication of color diagrams or figures. If the paper contains color graphics, a

surcharge of $100 per 100 reprints will be added to the normal charge for reprints.

ACS Policies for E-prints and Reprints. Under the ACS Articles on Request policy, the

Society will provide (free of charge) to all contributing authors a unique URL within the ACS

Web site that they may e-mail to colleagues or post on external Web sites. These author-directed

links are designed to facilitate distribution of an author’s published work to interested colleagues

in lieu of direct distribution of the PDF file by the author. The ACS Articles on Request policy

allows 50 downloads within the first year after Web publication and unlimited access via the

same author-directed links 12 months after Web publication.

When authors are sent the proof of their paper, they will receive a link to a website where they

may order paper reprints. They may also call Cierant Corporation—866-305-0111 from 9AM to

5PM EST. Reprints will be shipped within two weeks after the issue publication date. Neither the

Editors nor the Washington ACS Office keeps a supply of reprints; requests for single copies of

papers should be addressed to the corresponding author of the paper concerned.

ACS AuthorChoice Open Access. ACS AuthorChoice options establish fee-based mechanisms

for authors or their research funding agencies to sponsor the open availability of final published

articles on the Web. ACS AuthorChoice offers authors a wide range of open access license

options, such as Creative Commons licenses and provisions for immediate or 12-month

embargoed open access and includes ACS Certified Deposit. Authors will find useful information

about compliance with open access policies available here and FAQs here. Corresponding

authors who published with ACS during 2014 may have access to ACS Author Rewards, a $60M

stimulus program ACS provided to help authors transition to new open access publishing

models.

Authors must sign the Journals Publishing Agreement. Forms and complete instructions are

available here. After acceptance, authors will be presented with the opportunity to purchase an

ACS AuthorChoice option, and authors who do so will be presented with the appropriate license

at that time. For a review of all license options available, see here. For questions or further

assistance with ACS AuthorChoice, please reach out to [email protected].